导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.78% | 815/1050 |
| 近一周 | -1.24% | 238/1104 |
| 近一月 | -1.85% | 256/1102 |
| 近一季 | -7.31% | 710/1092 |
| 近半年 | -21.07% | 1006/1070 |
| 近一年 | 16.25% | 276/1018 |
| 近两年 | 83.28% | 271/926 |
| 近三年 | 69.52% | 153/833 |
| 成立以来 | 381.76% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
5.66% 120/1070 |
-8.41% 879/1101 |
- - |
- - |
| 2025 | 82.99% 33/1065 |
5.08% 409/1014 |
7.90% 161/1038 |
35.51% 267/1050 |
19.10% 9/1065 |
| 2024 | 7.74% 341/1011 |
11.73% 15/960 |
2.31% 181/983 |
7.28% 808/991 |
-12.14% 960/1011 |
| 2023 | -3.15% 166/952 |
7.64% 187/880 |
-6.20% 589/895 |
-1.28% 127/915 |
-2.83% 309/952 |
| 2022 | -6.34% 40/867 |
-9.28% 90/773 |
7.47% 377/806 |
-4.84% 62/845 |
0.96% 388/867 |
| 2021 | 45.30% 23/740 |
-5.10% 343/580 |
12.00% 311/659 |
19.78% 19/704 |
14.14% 29/740 |
| 2020 | 57.03% 205/554 |
5.61% 67/419 |
10.20% 399/466 |
15.48% 139/517 |
16.85% 171/554 |
| 2019 | 29.98% 289/410 |
23.32% 822/1146 |
-4.70% 688/1228 |
-0.74% 352/390 |
11.42% 123/410 |
| 2018 | -21.40% 97/349 |
- - |
-3.15% 145/990 |
-6.56% 543/1000 |
-6.62% 94/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 华商上游产业股票A VS. 东吴新产业精选股票A(580008) |